Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Payment Transactions (Tables)

v3.21.1
Share-Based Payment Transactions (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of expenses
    Year ended December 31,  
    2020     2019     2018  
    USD  
                   
Research and development expenses   $ 159     $ 138     $ 123  
General and administrative expenses     158       132       130  
                         
    $ 317     $ 270     $ 253  
Schedule of estimated using the binomial option pricing model
Description   2020     2019  
             
Risk-free interest rate     0.93 - 2.40 %     1.19% - 2.40 %
Expected volatility     65.63- 78.77 %     65.63%- 75.86 %
Dividend yield     0       0  
Contractual life     9.83 - 10       9.83 - 10  
Early Exercise Multiple (Suboptimal Factor)     2.5 - 3       2.5 - 3  
Exercise price (NIS)     0.25 - 2.344       0.28 - 2.344  
Schedule of weighted average exercise prices and modification in option plans of employees
    Shares subject to options outstanding  
    2020     2019     2018  
    Number     Weighted average exercise price     Number     Weighted average exercise price     Number     Weighted average exercise price  
          USD           USD           USD  
Outstanding at beginning of year     2,673,400       0.89       1,437,400       1.20       1,490,423       1.35  
Grants     9,250,000       0.08       1,240,000       0.44       -       -  
Forfeited/expired     -       -       (4,000 )     5.98       (53,023 )     7.53  
                                                 
Outstanding at end of year     11,923,400       0.28       2,673,400       0.89       1,437,400       1.20  
                                                 
Exercisable at end of year     2,900,276       0.74       1,134,653       1.39       736,155       2.41  
Schedule of options outstanding classified by exercise price
Outstanding   Exercisable  
Exercise price per share   Options outstanding     Weighted average remaining contractual life in years     Weighted average exercise
price per
share
    Options exercisable     Weighted average exercise
price per
share
 
$0.08 - $0.91     11,190,000       8.59     $ 0.16       2,192,500     $ 0.27  
$1.06 - $1.67     555,000       0.25     $ 0.06       529,376     $ 0.22  
$2.53 - $5.01     178,400       0.02     $ 0.06       178,400     $ 0.26  
      11,923,400                       2,900,276